Tenet Healthcare (THC)
(Real Time Quote from BATS)
$119.40 USD
+0.46 (0.39%)
Updated May 3, 2024 01:22 PM ET
1-Strong Buy of 5 1
A Value B Growth A Momentum A VGM
Brokerage Reports
Tenet Healthcare Corporation [THC]
Reports for Purchase
Showing records 341 - 360 ( 493 total )
Company: Tenet Healthcare Corporation
Industry: Medical - Hospital
Company: Tenet Healthcare Corporation
Industry: Medical - Hospital
Company: Tenet Healthcare Corporation
Industry: Medical - Hospital
Company: Tenet Healthcare Corporation
Industry: Medical - Hospital
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Tenet Healthcare Corporation
Industry: Medical - Hospital
Company: Tenet Healthcare Corporation
Industry: Medical - Hospital
Company: Tenet Healthcare Corporation
Industry: Medical - Hospital
Company: Tenet Healthcare Corporation
Industry: Medical - Hospital
Company: Tenet Healthcare Corporation
Industry: Medical - Hospital
Company: Tenet Healthcare Corporation
Industry: Medical - Hospital
Company: Tenet Healthcare Corporation
Industry: Medical - Hospital
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Tenet Healthcare Corporation
Industry: Medical - Hospital
4Q Slightly Below as Volumes Soften; 2017 EBITDA Guidance Is in Line
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: Tenet Healthcare Corporation
Industry: Medical - Hospital
Healthcare: Draft Bill Indicates Direction GOP Considering for ACA Replacement
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: Tenet Healthcare Corporation
Industry: Medical - Hospital
Company: Tenet Healthcare Corporation
Industry: Medical - Hospital
Company: Tenet Healthcare Corporation
Industry: Medical - Hospital
Adjusting Estimates Slightly to Better Reflect Guidance
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J
Company: Tenet Healthcare Corporation
Industry: Medical - Hospital
Company: Tenet Healthcare Corporation
Industry: Medical - Hospital
Healthcare Facilities and Services: ACA Repeal and Replace - Lots of Noise, but Risks Appear Modest
Provider: KEYBANC CAPITAL MARKETS
Analyst: GURDA J